Diagnosis and Treatment of Common Pancreatic Neuroendocrine Tumors_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

杨春明

Corresponding author：

Keywords：

胰腺神经内分泌肿瘤; 胰岛素瘤; 胃泌素瘤

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 杨春明. Diagnosis and Treatment of Common Pancreatic Neuroendocrine Tumors. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2012, 19(10): 1029-1032. doi: Copy

1.	Heller MT， Shah AT. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am， 2011， 49(3)：529-548.
2.	Eriksson B， Oberg K. Neuroendocrine tumors of the pancreas[J]. Br J Surg， 2000， 87(2)：129-131.
3.	Kloppel G， Perren A， Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors： the WHO classification[J]. Ann NY Acad Sci， 2004， 1014(1)：13-27.
4.	Kulke MH， Anthony LB， Bushe11 DL， et al. NANETS treatment guidelines： well-differentiated neuroendocrine tumors of the stomach and pancreas[J]. Pancreas， 2010， 39(6)：735-752.
5.	Yao JC， Hassan M， Phan A， et al. One hundred years after“carcinoid”： epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States[J]. J Clin Oncol， 2008， 26(18)：3063-3072.
6.	Lawrence B， Gustafsson BI， Chan A， et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin N Am， 2011， 40(1)： 1-18.
7.	Jensen RT， Niederle B， Mitry E， et al. Gastrinoma (duodenal and pancreatic)[J]. Neuroendocrinology， 2006， 84(1)：173-182.
8.	Kloppel G， Anlauf M. Gartrinoma-morphological aspects[J]. Wein Klin Wocherschr， 2007， 119(5)：574-584.
9.	Vanderveen K， Grant C. Insulinoma[J]. Cancer Treat Res， 2010， 153(2)：235-252.
10.	Jensen RT， Cadiot G， Brandi ML. ENETs consensus guidelines for the management of patients with digestive neuroendocrineneoplasms：functional pancreatic endocrine tumor syndromes[J]. Neuroendocrinology， 2012， 95(1)：98-119.
11.	Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology[J]. Arch Pathol Lab Med， 2008， 132(8)：1285-1289.
12.	Bosman FT. WHO Classification of Tumors of the DigestiveSystem[M]. Lyon ， IARC Press， 2010.
13.	De Herder WW， Niederle B， Scoazes JY， et al. Well-differentiated pancreatic tumor/carcinoma：insulinoma[J]. Neuroendoocrinology， 2006， 84(1)：183-188.
14.	Vinik AI， Gonzales MRC. New and emerging syndromes due to neuroendocrine tumors[J]. Endocrinol Metab Clin N Am， 2011， 40(1)：19-63.
15.	Osefo N， Ito T， Jensen RT. Gastric acid hypersecetory states：recent insights and advances[J]. Curr Gastroenterol Rep， 2009， 11(4)：433-441.
16.	Metz DG， Jensen RT. Gastrointestinal neuroendocrine tumors：pancreatic endocrine tumors[J]. Gastroenterology， 2008， 135(5)：1469-1492.
17.	Heller MT， Shah AB. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am， 2011， 49(3)：529-548.
18.	Morrow EH， Norton JA. Surgical management of Zollinger-Ellison syndrome； state of the art[J]. Surg Clin North Am， 2009， 89(5)：1091-1103.
19.	Ruf J， Heuck F， Schiefer J， et al. Impact of multiple 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors[J]. Neuendocrinology， 2010， 91(1)：101-109.
20.	Sundin A， Garake U， Orlefors H. Nuclear imaging of neurooendocrine tumors[J]. Best Pract Res Clin Endocrinal Metab， 2007， 21(1)：69-85.
21.	Norton JA， Jeusen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellisonsyndrome[J]. Ann Surg ， 2004， 240(5)：757-773.
22.	Gouolet P， Muret A， Bingut C， et al. Risk factors and causes of death in MEN-1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients[J]. World J Surg， 2010， 34(2)：249-255.
23.	Figueiredo FA， Giovannini M， Monges G， et al. Pancreaticendocrine tumors：a large single center experience[J]. Pancrease， 2009， 38(8)：936-940.
24.	Boudrcause JP. Surgery for gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am， 2011， 40(1)：163-171.
25.	Woltering E， Cundiff， Lyous J. Neuroendocrine tumors of the gastroenteropancreatic axis//Silberman H， Silberman AW. ed. Principles and Practice of Surgical Oncology[M]. Philadephia：Lippincott Williams & Wilkins， 2010：769-800.
26.	Lorenz K， Dralle H. Surgical treatment of sporadic gastrinoma[J]. Wien Klin Wochenschr， 2007， 119(19-20)：597-601.
27.	Grobmyer SR， Vogel SB， McGuigan JE， et al. Reoperativesurgery in sporadic Zollinger-Ellison Syndrome：long-term results[J]. J Am Coll Surg， 2009， 208(6)：718-722.
28.	Fendrich V， Langer P， Waldmann J， et al. Management ofsporadic and multiple endocrine neoplasia type 1 gastrinomas[J]. Br J Surg， 2007， 94(11)：1331-1341.
29.	Fernandaz-Cruz L， Blanco L， Cosa R， et al. Is laparoscopic resection adequate in patients with neoroendocrine pancreatictumors[J]. World J Surg， 2008， 32(5)：904-917.
30.	Isla A， Arbuckle JD， Kekis PB， et al. Laparoscopic management of insulinoma[J]. Br J Srug， 2009， 96(2)：185-190.
31.	Gimm V， König E， Thanh PN， et al. Intraoperative quick insulin assay to confirm complete resection of insulinomas guided by selective arterial calcium injection (SACI)[J]. Langenbecks Arch Surg， 2007， 392(6)：679-684.
32.	Akerstron G， Hellman P. Surgery on neuroendocrine tumors[J]. Best Pract Res Clin Endocrinol Metab， 2007， 21(1)：87-109.
33.	Joseph S， Wang YZ， Boudreaux JP， et al. Neuroendocrinetumors： current recommendations for diagnosis and surgical management[J]. Endocrinol Metab Clin North Am， 2011， 40(1)：205-231.

1. Heller MT， Shah AT. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am， 2011， 49(3)：529-548.
2. Eriksson B， Oberg K. Neuroendocrine tumors of the pancreas[J]. Br J Surg， 2000， 87(2)：129-131.
3. Kloppel G， Perren A， Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors： the WHO classification[J]. Ann NY Acad Sci， 2004， 1014(1)：13-27.
4. Kulke MH， Anthony LB， Bushe11 DL， et al. NANETS treatment guidelines： well-differentiated neuroendocrine tumors of the stomach and pancreas[J]. Pancreas， 2010， 39(6)：735-752.
5. Yao JC， Hassan M， Phan A， et al. One hundred years after“carcinoid”： epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States[J]. J Clin Oncol， 2008， 26(18)：3063-3072.
6. Lawrence B， Gustafsson BI， Chan A， et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin N Am， 2011， 40(1)： 1-18.
7. Jensen RT， Niederle B， Mitry E， et al. Gastrinoma (duodenal and pancreatic)[J]. Neuroendocrinology， 2006， 84(1)：173-182.
8. Kloppel G， Anlauf M. Gartrinoma-morphological aspects[J]. Wein Klin Wocherschr， 2007， 119(5)：574-584.
9. Vanderveen K， Grant C. Insulinoma[J]. Cancer Treat Res， 2010， 153(2)：235-252.
10. Jensen RT， Cadiot G， Brandi ML. ENETs consensus guidelines for the management of patients with digestive neuroendocrineneoplasms：functional pancreatic endocrine tumor syndromes[J]. Neuroendocrinology， 2012， 95(1)：98-119.
11. Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology[J]. Arch Pathol Lab Med， 2008， 132(8)：1285-1289.
12. Bosman FT. WHO Classification of Tumors of the DigestiveSystem[M]. Lyon ， IARC Press， 2010.
13. De Herder WW， Niederle B， Scoazes JY， et al. Well-differentiated pancreatic tumor/carcinoma：insulinoma[J]. Neuroendoocrinology， 2006， 84(1)：183-188.
14. Vinik AI， Gonzales MRC. New and emerging syndromes due to neuroendocrine tumors[J]. Endocrinol Metab Clin N Am， 2011， 40(1)：19-63.
15. Osefo N， Ito T， Jensen RT. Gastric acid hypersecetory states：recent insights and advances[J]. Curr Gastroenterol Rep， 2009， 11(4)：433-441.
16. Metz DG， Jensen RT. Gastrointestinal neuroendocrine tumors：pancreatic endocrine tumors[J]. Gastroenterology， 2008， 135(5)：1469-1492.
17. Heller MT， Shah AB. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am， 2011， 49(3)：529-548.
18. Morrow EH， Norton JA. Surgical management of Zollinger-Ellison syndrome； state of the art[J]. Surg Clin North Am， 2009， 89(5)：1091-1103.
19. Ruf J， Heuck F， Schiefer J， et al. Impact of multiple 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors[J]. Neuendocrinology， 2010， 91(1)：101-109.
20. Sundin A， Garake U， Orlefors H. Nuclear imaging of neurooendocrine tumors[J]. Best Pract Res Clin Endocrinal Metab， 2007， 21(1)：69-85.
21. Norton JA， Jeusen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellisonsyndrome[J]. Ann Surg ， 2004， 240(5)：757-773.
22. Gouolet P， Muret A， Bingut C， et al. Risk factors and causes of death in MEN-1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients[J]. World J Surg， 2010， 34(2)：249-255.
23. Figueiredo FA， Giovannini M， Monges G， et al. Pancreaticendocrine tumors：a large single center experience[J]. Pancrease， 2009， 38(8)：936-940.
24. Boudrcause JP. Surgery for gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am， 2011， 40(1)：163-171.
25. Woltering E， Cundiff， Lyous J. Neuroendocrine tumors of the gastroenteropancreatic axis//Silberman H， Silberman AW. ed. Principles and Practice of Surgical Oncology[M]. Philadephia：Lippincott Williams & Wilkins， 2010：769-800.
26. Lorenz K， Dralle H. Surgical treatment of sporadic gastrinoma[J]. Wien Klin Wochenschr， 2007， 119(19-20)：597-601.
27. Grobmyer SR， Vogel SB， McGuigan JE， et al. Reoperativesurgery in sporadic Zollinger-Ellison Syndrome：long-term results[J]. J Am Coll Surg， 2009， 208(6)：718-722.
28. Fendrich V， Langer P， Waldmann J， et al. Management ofsporadic and multiple endocrine neoplasia type 1 gastrinomas[J]. Br J Surg， 2007， 94(11)：1331-1341.
29. Fernandaz-Cruz L， Blanco L， Cosa R， et al. Is laparoscopic resection adequate in patients with neoroendocrine pancreatictumors[J]. World J Surg， 2008， 32(5)：904-917.
30. Isla A， Arbuckle JD， Kekis PB， et al. Laparoscopic management of insulinoma[J]. Br J Srug， 2009， 96(2)：185-190.
31. Gimm V， König E， Thanh PN， et al. Intraoperative quick insulin assay to confirm complete resection of insulinomas guided by selective arterial calcium injection (SACI)[J]. Langenbecks Arch Surg， 2007， 392(6)：679-684.
32. Akerstron G， Hellman P. Surgery on neuroendocrine tumors[J]. Best Pract Res Clin Endocrinol Metab， 2007， 21(1)：87-109.
33. Joseph S， Wang YZ， Boudreaux JP， et al. Neuroendocrinetumors： current recommendations for diagnosis and surgical management[J]. Endocrinol Metab Clin North Am， 2011， 40(1)：205-231.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Diagnosis and Treatment of Common Pancreatic Neuroendocrine Tumors

Abstract Full text Figures/Tables Video References Cited by

Format

Content